In short. Depth, dilution and spacing drive the risk. What a lump means, what can be done about it, and why it is not always correctable once it has formed.
Key points
- Depth, dilution and spacing are decisions made in the room rather than on a label.
- That is why the useful question before a course is not which product is used but how the material is prepared for the area, how deep it will be placed, and how far apart the sessions will be.
- Those three answers predict the outcome better than any brand comparison.
Firm lumps are the risk that most shapes how this substance should be used, and they are the reason the assessment should spend more time on preparation and depth than on products. They are uncommon, they appear later than most patients expect, and they are difficult to correct once established. Prevention is therefore not advice about risk; it is the whole of the risk management.
Why they form
The material is placed as particles that the tissue responds to by building collagen around each one. When the particles sit too close together, when they are placed too near the surface, or when the preparation does not suit the area, that response can become a firm mass rather than an even layer. Sessions crowded together add to the risk in the same way, because the tissue is still responding to what was already placed. The same process that produces the wanted change produces the lump, and what separates them is how evenly the material is distributed and how much tissue covers it.
How they present
Firmness under the skin in the first weeks is common and usually settles, and it is not the same finding as a lump. A nodule is typically firmer, more defined and slower to change, and it often appears in the months when the result is being judged rather than immediately, which is why the reviews examine the tissue as well as the appearance. A delayed inflammatory response can appear weeks or months after treatment and may need treatment in its own right.
Why technique outweighs the product
Depth, dilution and spacing are decisions made in the room rather than on a label. That is why the useful question before a course is not which product is used but how the material is prepared for the area, how deep it will be placed, and how far apart the sessions will be. Those three answers predict the outcome better than any brand comparison.
How they are managed
There is no dissolving agent, so the options are limited. Small firm areas may be observed, because some soften as the tissue remodels. Massage is sometimes prescribed, in a specific way and for a specific period. Injected treatment may be used where a delayed reaction has an inflammatory component. Removal is occasionally the answer for a problem that cannot be managed otherwise.
What should prompt an assessment
- A firm area that is growing, is painful, or has become visible under the skin.
- Redness, warmth, swelling or tenderness over a treated area, or any fever.
- A lump appearing months after treatment, even when it is not painful.
None of this makes the treatment unreasonable. It makes the plan, and the person carrying it out, the part of the decision that matters most. A patient who asks how the substance is prepared, how deep it will be placed and what will be done if a firm area appears months later has done more for their own outcome than any comparison of products could achieve.
Frequently asked questions
When do lumps usually appear after this treatment?
Often later than patients expect, in the months when the result is being judged rather than in the first fortnight. Firmness in the first weeks is common and usually settles. A firm area that is growing, painful or visible is a different finding and needs assessment.
Can a lump be dissolved?
No, because there is no agent that reverses this substance. Management means observation, massage in the way it is prescribed, injected treatment where there is an inflammatory component, and occasionally removal. It is a pathway rather than a correction, and it does not guarantee the previous contour.
What makes a lump more likely?
How deeply the material is placed, how it is prepared for the area, and how far apart the sessions are. Placing too superficially and crowding sessions are the two most common contributors, and both are decisions made by the person injecting rather than properties of the substance.
Risks & Limitations
- Irreversibility: there is no agent that reverses this substance. An uneven or unwanted result is managed over time, with injected treatment, or occasionally by removal, and never switched off.
- Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment, most often in the window when the result is being judged.
- Unevenness or over-correction, which is harder to correct than under-treatment in an area that cannot be dissolved.
- Nothing is visible on the day and the treated area may look unchanged for several weeks. This is expected rather than a sign the treatment has failed.
- Infection or inflammation at an injection site, which needs prompt assessment rather than waiting.
- Tenderness, swelling, occasional bruising and occasional headache after treatment.
- The result develops over months, cannot be judged before six months, is not permanent, and declines gradually after its fullest point; the face continues to age.
When to Seek Care
- A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
- Redness, warmth, swelling or pus at an injection site, or fever.
- Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
- Increasing pain, or pain out of proportion to the injection.
- Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable and skin safety information
- American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
- U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
- National Medical Products Administration (NMPA, China) — approved product status
- Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.